Information concerning the Group's Consolidated Operations (Tables)
|
6 Months Ended |
Jun. 30, 2026 |
|---|
| Text block1 [abstract] |
|
| Revenues by Nature |
Revenues by nature
|
|
|
|
|
|
|
|
|
|
For the six-month period ended June 30, |
|
|
|
2025 |
|
|
2026 |
|
|
$ in thousands |
|
Collaboration agreements |
|
|
26,869 |
|
|
|
10,669 |
|
Licenses |
|
|
417 |
|
|
|
200 |
|
Products & services |
|
|
94 |
|
|
|
137 |
|
Total revenues |
|
|
27,380 |
|
|
|
11,006 |
|
Revenues by nature
|
|
|
|
|
|
|
|
|
|
|
For the three-month period ended June 30, |
|
|
|
2025 |
|
|
2026 |
|
|
|
$ in thousands |
|
Collaboration agreements |
|
|
16,572 |
|
|
|
5,043 |
|
Licenses |
|
|
123 |
|
|
|
127 |
|
Products & services |
|
|
29 |
|
|
|
59 |
|
Total revenues |
|
|
16,725 |
|
|
|
5,229 |
|
|
| Revenues By Country of Origin and Other Income |
Revenues by country of origin and other income
|
|
|
|
|
|
|
|
|
|
For the six-month period ended June 30, |
|
|
|
2025 |
|
|
2026 |
|
|
$ in thousands |
|
From France |
|
|
27,380 |
|
|
|
11,006 |
|
Revenues |
|
|
27,380 |
|
|
|
11,006 |
|
Research tax credit subsidy |
|
|
2,842 |
|
|
|
3,446 |
|
Other subsidies and other |
|
|
- |
|
|
|
- |
|
Other income |
|
|
2,842 |
|
|
|
3,446 |
|
Total revenues and other income |
|
|
30,222 |
|
|
|
14,452 |
|
Revenues by country of origin and other income
|
|
|
|
|
|
|
|
|
|
|
For the three-month period ended June 30, |
|
|
|
2025 |
|
|
2026 |
|
|
|
$ in thousands |
|
From France |
|
|
16,725 |
|
|
|
5,229 |
|
Revenues |
|
|
16,725 |
|
|
|
5,229 |
|
Research tax credit |
|
|
1,505 |
|
|
|
1,675 |
|
Subsidies and other |
|
|
(36 |
) |
|
|
- |
|
Other income |
|
|
1,469 |
|
|
|
1,675 |
|
Total revenues and other income |
|
|
18,193 |
|
|
|
6,904 |
|
|
| Details of Operating Expenses by Nature |
|
|
|
|
|
|
|
|
|
|
For the six-month period ended June 30, |
|
Research and development expenses |
|
2025 |
|
|
2026 |
|
|
|
|
|
|
|
|
Wages and salaries |
|
|
(17,485 |
) |
|
|
(20,377 |
) |
Social charges on stock option grants |
|
|
(286 |
) |
|
|
(726 |
) |
Non-cash stock-based compensation expense |
|
|
(1,536 |
) |
|
|
(2,678 |
) |
Personnel expenses |
|
|
(19,307 |
) |
|
|
(23,781 |
) |
Purchases and external expenses |
|
|
(16,071 |
) |
|
|
(19,758 |
) |
Depreciation and amortization expenses (incl. right of use amortization) |
|
|
(9,229 |
) |
|
|
(8,232 |
) |
Other |
|
|
(405 |
) |
|
|
(393 |
) |
Total research and development expenses |
|
|
(45,012 |
) |
|
|
(52,165 |
) |
|
|
|
|
|
|
|
|
For the six-month period ended June 30, |
|
Selling, general and administrative expenses |
|
2025 |
|
|
2026 |
|
|
|
|
|
|
|
|
Wages and salaries |
|
|
(3,277 |
) |
|
|
(3,723 |
) |
Social charges on stock option grants |
|
|
(154 |
) |
|
|
(322 |
) |
Non-cash stock-based compensation expense |
|
|
(722 |
) |
|
|
(1,274 |
) |
Personnel expenses |
|
|
(4,153 |
) |
|
|
(5,319 |
) |
Purchases and external expenses |
|
|
(4,440 |
) |
|
|
(4,675 |
) |
Depreciation and amortization expenses (incl. right of use amortization) |
|
|
(718 |
) |
|
|
(715 |
) |
Other |
|
|
(469 |
) |
|
|
(620 |
) |
Total selling, general and administrative expenses |
|
|
(9,780 |
) |
|
|
(11,329 |
) |
|
|
|
|
|
|
|
|
For the six-month period ended June 30, |
|
Personnel expenses |
|
2025 |
|
|
2026 |
|
|
|
|
|
|
|
|
Wages and salaries |
|
|
(20,763 |
) |
|
|
(24,100 |
) |
Social charges on stock option grants |
|
|
(439 |
) |
|
|
(1,048 |
) |
Non-cash stock-based compensation expense |
|
|
(2,258 |
) |
|
|
(3,952 |
) |
Total personnel expenses |
|
|
(23,460 |
) |
|
|
(29,101 |
) |
|
|
|
|
|
|
|
|
For the six-month period ended June 30, |
|
|
|
2025 |
|
|
2026 |
|
|
|
|
|
|
|
|
Other operating income |
|
|
804 |
|
|
|
353 |
|
|
|
|
|
|
|
|
|
|
|
|
For the three-month period ended June 30, |
|
Research and development expenses |
|
2025 |
|
|
2026 |
|
|
|
|
|
|
|
|
Wages and salaries |
|
|
(8,821 |
) |
|
|
(9,041 |
) |
Social charges on stock option grants |
|
|
(35 |
) |
|
|
10 |
|
Non-cash stock-based compensation expense |
|
|
(885 |
) |
|
|
(1,550 |
) |
Personnel expenses |
|
|
(9,741 |
) |
|
|
(10,581 |
) |
Purchases and external expenses |
|
|
(8,493 |
) |
|
|
(10,171 |
) |
Depreciation and amortization expenses (incl. right of use amortization) |
|
|
(4,652 |
) |
|
|
(4,055 |
) |
Other |
|
|
(194 |
) |
|
|
(169 |
) |
Total research and development expenses |
|
|
(23,080 |
) |
|
|
(24,976 |
) |
|
|
|
- |
|
|
|
- |
|
|
|
For the three-month period ended June 30, |
|
Selling, general and administrative expenses |
|
2025 |
|
|
2026 |
|
|
|
|
|
|
|
|
Wages and salaries |
|
|
(1,650 |
) |
|
|
(1,994 |
) |
Social charges on stock option grants |
|
|
(14 |
) |
|
|
(16 |
) |
Non-cash stock-based compensation expense |
|
|
(398 |
) |
|
|
(739 |
) |
Personnel expenses |
|
|
(2,061 |
) |
|
|
(2,749 |
) |
Purchases and external expenses |
|
|
(2,425 |
) |
|
|
(2,355 |
) |
Depreciation and amortization expenses (incl. right of use amortization) |
|
|
(365 |
) |
|
|
(357 |
) |
Other |
|
|
(227 |
) |
|
|
(277 |
) |
Total selling, general and administrative expenses |
|
|
(5,078 |
) |
|
|
(5,739 |
) |
|
|
|
- |
|
|
|
- |
|
|
|
For the three-month period ended June 30, |
|
Personnel expenses |
|
2025 |
|
|
2026 |
|
|
|
|
|
|
|
|
Wages and salaries |
|
|
(10,471 |
) |
|
|
(11,036 |
) |
Social charges on stock option grants |
|
|
(49 |
) |
|
|
(5 |
) |
Non-cash stock-based compensation expense |
|
|
(1,282 |
) |
|
|
(2,289 |
) |
Total personnel expenses |
|
|
(11,802 |
) |
|
|
(13,330 |
) |
|
|
|
- |
|
|
|
- |
|
|
|
For the three-month period ended June 30, |
|
|
|
2025 |
|
|
2026 |
|
|
|
|
|
|
|
|
Other operating income (expenses) |
|
|
378 |
|
|
|
290 |
|
|
| Details of Financial Income and Expenses |
|
|
|
|
|
|
|
|
|
|
For the six-month period ended June 30, |
|
Financial income and expenses |
|
2025 |
|
|
2026 |
|
|
|
|
|
Interest income from cash, cash equivalents and financial assets |
|
|
5,107 |
|
|
|
3,391 |
|
Foreign exchange gains |
|
|
4,705 |
|
|
|
4,256 |
|
Gain on fair value measurement |
|
|
1,766 |
|
|
|
8,761 |
|
Other financial income |
|
|
- |
|
|
|
159 |
|
Financial income |
|
|
11,578 |
|
|
|
16,568 |
|
Interest on financial liabilities |
|
|
(2,802 |
) |
|
|
(3,118 |
) |
Foreign exchange losses |
|
|
(25,527 |
) |
|
|
(2,708 |
) |
Loss on fair value measurement |
|
|
(182 |
) |
|
|
(437 |
) |
Interest on lease liabilities |
|
|
(1,164 |
) |
|
|
(823 |
) |
Other financial expenses |
|
|
- |
|
|
|
(305 |
) |
Financial expenses |
|
|
(29,675 |
) |
|
|
(7,392 |
) |
Net financial gain (loss) |
|
|
(18,098 |
) |
|
|
9,176 |
|
|
|
|
|
|
|
|
|
|
|
|
For the three-month period ended June 30, |
|
Financial income and expenses |
|
2025 |
|
|
2026 |
|
|
|
|
|
Interest income from cash, cash equivalents and financial assets |
|
|
2,195 |
|
|
|
1,546 |
|
Foreign exchange gains |
|
|
3,351 |
|
|
|
912 |
|
Gain on fair value measurement |
|
|
- |
|
|
|
2,255 |
|
Other financial income |
|
|
- |
|
|
|
26 |
|
Financial income |
|
|
5,545 |
|
|
|
4,739 |
|
Interest on financial liabilities |
|
|
(1,500 |
) |
|
|
(1,603 |
) |
Foreign exchange losses |
|
|
(17,358 |
) |
|
|
(998 |
) |
Loss on fair value measurement |
|
|
(282 |
) |
|
|
- |
|
Interest on lease liabilities |
|
|
(556 |
) |
|
|
(410 |
) |
Other financial expenses |
|
|
- |
|
|
|
(1 |
) |
Financial expenses |
|
|
(19,695 |
) |
|
|
(3,011 |
) |
Net financial gain (loss) |
|
|
(14,150 |
) |
|
|
1,727 |
|
|
| Disclosure of Income Tax |
|
|
|
|
|
|
|
|
|
|
For the six-month period ended June 30, |
|
|
|
2025 |
|
|
2026 |
|
Income tax |
|
|
0 |
|
|
|
(72 |
) |
|
|
|
|
|
|
|
|
|
|
For the three-month period ended June 30, |
|
|
|
2025 |
|
|
2026 |
|
Income tax |
|
|
0 |
|
|
|
(25 |
) |
|